Reporting pharmacoeconomic evaluations

被引:0
|
作者
C. I. Carswell
J. A. Paladino
机构
[1] Adis International Limited,
来源
PharmacoEconomics | 2005年 / 23卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1073 / 1073
相关论文
共 50 条
  • [1] Reporting pharmacoeconomic evaluations
    Carswell, CI
    Paladino, JA
    PHARMACOECONOMICS, 2005, 23 (11) : 1073 - 1073
  • [2] PHARMACOECONOMIC EVALUATIONS IN MEDICINE
    FROEMMING, SH
    COLD, JA
    WELLS, BG
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (05): : 431 - 431
  • [3] Accounting for Noncompliance in Pharmacoeconomic Evaluations
    Dyfrig A. Hughes
    Adrian Bagust
    Alan Haycox
    Tom Walley
    PharmacoEconomics, 2001, 19 : 1185 - 1197
  • [4] The need for pharmacoeconomic evaluations in the NHS
    Griffin, JP
    PHARMACOECONOMICS, 1998, 14 (03) : 241 - 250
  • [5] SUBSTANTIATION IN PHARMACOECONOMIC EVALUATIONS - COMMENT
    LANGLEY, PC
    ANNALS OF PHARMACOTHERAPY, 1995, 29 (09) : 942 - 943
  • [6] The Need for Pharmacoeconomic Evaluations in the NHS
    John P. Griffin
    PharmacoEconomics, 1998, 14 : 241 - 250
  • [7] Pharmacoeconomic evaluations of antifungal therapies
    Hennen, Cynthia R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (07) : 1751 - 1758
  • [8] Pharmacoeconomic evaluations of immunosuppressive agents
    Mozaffari, E
    TRANSPLANTATION PROCEEDINGS, 1999, 31 (4A) : 53S - 54S
  • [9] Accounting for noncompliance in pharmacoeconomic evaluations
    Hughes, DA
    Bagust, A
    Haycox, A
    Walley, T
    PHARMACOECONOMICS, 2001, 19 (12) : 1185 - 1197
  • [10] The Role of Pharmacoeconomic Evaluations in Disease Management
    Kenneth Chang
    David Nash
    PharmacoEconomics, 1998, 14 : 11 - 17